Recombinant interferon alpha 2a, thymopentin and low doses of cytosine arabinoside for the treatment of myelodysplastic syndromes: a pilot study.

scientific article published in January 1995

Recombinant interferon alpha 2a, thymopentin and low doses of cytosine arabinoside for the treatment of myelodysplastic syndromes: a pilot study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/10428199509049773
P698PubMed publication ID7719240

P50authorFrancesco BuccisanoQ41237865
Adriano VendittiQ41237877
Giovanni Del PoetaQ56950902
Sandro GrelliQ59243018
P2093author name stringA Mastino
G Papa
C Favalli
E Garaci
R Stasi
M T Scimò
P2860cites workDeletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasiaQ28266438
Proposals for the classification of the myelodysplastic syndromesQ28275931
Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell linesQ30502375
Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemiaQ33457422
Involvement of thymosin beta 4 and endoproteinase Asp-N in the biosynthesis of the tetrapeptide AcSerAspLysPro a regulator of the hematopoietic systemQ34248639
Human preleukaemia: do we have a model?Q36027591
Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificityQ39337365
The 5q-anomalyQ39822203
Abolished Production of Interferon by Leucocytcs of Patients with the Acquired Cytogcnetic Abnormalities 5q — or — 5 in Secondary and de-Novo Acute Non-lymphocytic LeukaemiaQ40858957
Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemiaQ41862826
Enhanced NK cell activity in mice injected with interferon and interferon inducersQ41935188
Synergistic effect of thymosin alpha 1 and alpha beta-interferon on NK activity in tumor-bearing miceQ44980347
All-trans retinoic acid improves erythropoiesis in myelodysplastic syndromes: a case reportQ46034774
A common progenitor for human myeloid and lymphoid cellsQ59048641
P433issue3-4
P921main subjectcytarabineQ180983
P304page(s)335-342
P577publication date1995-01-01
P1433published inLeukemia & LymphomaQ6534493
P1476titleRecombinant interferon alpha 2a, thymopentin and low doses of cytosine arabinoside for the treatment of myelodysplastic syndromes: a pilot study
P478volume16